| Tag | Content |
|---|
EnhancerAtlas ID | HS187-11919 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr19:10532040-10533060 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CEBPA | MA0102.3 | chr19:10532817-10532828 | GATTGTGCAAT | - | 6.32 | | GFI1 | MA0038.2 | chr19:10532773-10532785 | TGCAGTGATTGG | - | 6.44 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_60895 | chr19:10518941-10535846 | DHL6 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I010421 | chr19 | 10532501 | 10532989 |
|
Enhancer Sequence | GTCTGTATTC TTGGTGACAG TGCAGAACAG CTGCTAAGCT GGGAACCACT TGGAGGGACC 60
TTCCTGGGGG CACTATACTG AGGGCTAGAT TCGCAGTGTT TGGGGTACTC TTGGAGCACT 120
CCATAAGGGG GTGCCTGCTA GGACCAGGAT CTTTACTTCA GGGTGGGGTG CTCTCAGGGT 180
CCTTCTAGGG GATGGAGGAC TCTATTGCGG GGATGTTAGT GGACTCCTCC TGCAGCAGCT 240
GGGGTCAGAA ATCCAGAGGG TGCCTCTTGG GGGAGCACTG TTTTGGGAGC CTTGCGTTAG 300
ATTGGAGTTC CCCTCTCAGG GCAAGAGTGT TAGCGTTAAG TAGCTGTTCA GAGGCAGGAA 360
ACAGTGGAGG GGGGGCGCAG TCCCAGCACA GAGGGAAGGA GTCCCTGACT GCAGAGGTGA 420
CAGCATAGTG AGGGTGCATG TGTGTTGAGC TTGGTCTCCT CTGAGGGTAT TCTCCGATTG 480
ACCTCCGTTT GCTCCAGCTG TCCGGGTATG ACCAGCTGTG GCTACCTCAG TTGTGTGCTC 540
TGTGTGAGCT TCTGGGGTCT TGTGATGGTG ACACGATGAC TCTGTGTCCT CCAGGGACAG 600
TGTAATTGTG ACAGTGTGAC TGTGTATTTC CAGGGTAGTG TGACTGTGTG TTTCTGGGAC 660
AGGGTTTGCG ACAGTGACTG TGTGTGCTCC AAGAATGCTG TGACTGTCAC AGGGTGACTG 720
TGGCCTCATG GGATGCAGTG ATTGGGATAG AGTGACTGTT TCTGCTCCTA GGACAGTGAT 780
TGTGCAATGG TGTTGGTGGT CTAGGGACAA TGTGATTGTG ACAGTGTCAT TTCTGGCATG 840
CAGTGATTGT GGCACTGGGG TGTTTACACT TGGGGAACAA TGTGATTGAG TTCGTGGAAC 900
AGTCTGTGCT CCTTGGACAC TGTGATTGAA ACACAGTGGC TGTGTGTTAG TCTTCACCAG 960
GTGCTCACGT CTGAGCGTCG GTGCTCTGAC ATGTGGTCTG TGTTCCCTCT GCCTGGTGTA 1020
|
